PES Drugs and Therapeutics and Ethics committees present guidelines for Growth Hormone and Insulin-like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency.
Read MoreThe first international consensus statement on diagnosis and management of Silver–Russell syndrome presented by 41 task force members from 16 countries.
Read MoreRecommendations for healthcare providers on how to partner with the patient family in appropriate disclosure of diagnosis of Klinefelter syndrome to their child.
Read More